Kavar Capital Partners LLC increased its position in shares of Cerner Co. (NASDAQ:CERN) by 8.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 43,257 shares of the company’s stock after acquiring an additional 3,354 shares during the quarter. Cerner comprises about 1.2% of Kavar Capital Partners LLC’s investment portfolio, making the stock its 25th largest position. Kavar Capital Partners LLC’s holdings in Cerner were worth $3,171,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Nelson Roberts Investment Advisors LLC bought a new stake in Cerner in the first quarter valued at about $25,000. Berman Capital Advisors LLC increased its holdings in Cerner by 115.3% in the second quarter. Berman Capital Advisors LLC now owns 381 shares of the company’s stock valued at $27,000 after purchasing an additional 204 shares during the last quarter. Advisory Alpha LLC bought a new stake in Cerner in the first quarter valued at about $28,000. Creative Financial Designs Inc. ADV increased its holdings in Cerner by 303.4% in the first quarter. Creative Financial Designs Inc. ADV now owns 710 shares of the company’s stock valued at $41,000 after purchasing an additional 534 shares during the last quarter. Finally, Valeo Financial Advisors LLC bought a new stake in Cerner in the second quarter valued at about $49,000. 82.59% of the stock is currently owned by institutional investors and hedge funds.

Shares of CERN stock traded up $0.44 on Thursday, hitting $69.86. 28,831 shares of the stock were exchanged, compared to its average volume of 2,410,672. The company has a debt-to-equity ratio of 0.22, a current ratio of 2.52 and a quick ratio of 2.50. The stock has a market cap of $22.36 billion, a price-to-earnings ratio of 31.50, a P/E/G ratio of 2.01 and a beta of 0.92. The business has a 50-day moving average of $73.01. Cerner Co. has a fifty-two week low of $48.78 and a fifty-two week high of $76.47.

Cerner (NASDAQ:CERN) last posted its quarterly earnings data on Wednesday, July 24th. The company reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.58 by $0.02. The company had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.44 billion. Cerner had a return on equity of 15.14% and a net margin of 10.75%. Cerner’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.62 earnings per share. As a group, equities research analysts expect that Cerner Co. will post 2.43 earnings per share for the current fiscal year.

The company also recently disclosed a special dividend, which was paid on Friday, July 26th. Stockholders of record on Tuesday, June 18th were given a dividend of $0.18 per share. The ex-dividend date was Monday, June 17th. Cerner’s dividend payout ratio is currently 32.58%.

A number of equities research analysts recently commented on the company. BidaskClub downgraded Cerner from a “hold” rating to a “sell” rating in a report on Thursday, July 25th. Cantor Fitzgerald increased their price target on Cerner from $75.00 to $85.00 and gave the stock an “overweight” rating in a report on Monday, July 8th. ValuEngine upgraded Cerner from a “hold” rating to a “buy” rating in a report on Wednesday, May 1st. Zacks Investment Research downgraded Cerner from a “buy” rating to a “hold” rating and set a $77.00 price target for the company. in a report on Monday, July 29th. Finally, Wells Fargo & Co increased their price target on Cerner from $72.00 to $80.00 and gave the stock an “outperform” rating in a report on Thursday, July 25th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and eleven have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $73.36.

In other news, EVP Julie M. Wilson sold 93,500 shares of the company’s stock in a transaction dated Monday, May 20th. The stock was sold at an average price of $69.57, for a total transaction of $6,504,795.00. Following the completion of the transaction, the executive vice president now directly owns 45,510 shares of the company’s stock, valued at $3,166,130.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director William D. Zollars sold 1,400 shares of the company’s stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $72.11, for a total value of $100,954.00. The disclosure for this sale can be found here. Insiders have sold 383,000 shares of company stock valued at $26,729,803 over the last ninety days. 0.75% of the stock is owned by insiders.

Cerner Profile

Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Featured Story: Stochastic Momentum Index (SMI)

Institutional Ownership by Quarter for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.